SOPHiA GENETICS SA (SOPH) Reports Q4 Loss, Tops Revenue Estimates

Group 1 - SOPHiA GENETICS reported a quarterly loss of $0.23 per share, slightly better than the Zacks Consensus Estimate of a loss of $0.24, and an improvement from a loss of $0.37 per share a year ago, indicating an earnings surprise of 4.17% [1] - The company generated revenues of $17.73 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.36% and showing an increase from $17.05 million in the same quarter last year [2] - SOPHiA GENETICS shares have increased by approximately 16.3% since the beginning of the year, contrasting with a decline of 0.5% in the S&P 500 [3] Group 2 - The current consensus EPS estimate for the upcoming quarter is -$0.21 on revenues of $17.5 million, while for the current fiscal year, the estimate is -$0.81 on revenues of $74.96 million [7] - The Zacks Industry Rank places Medical Info Systems in the top 28% of over 250 Zacks industries, suggesting that companies in the top 50% outperform those in the bottom 50% by more than a factor of 2 to 1 [8]